A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities

Clinical trial NCT03410927 · TERMINATED

Trial details

NCT number: NCT03410927
Sponsor: Taiho Oncology, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors With HER2 Abnormalities Advanced Solid Tumors With HER3 Abnormalities

Start date: 2018-04-06
Primary completion: 2022-06-09
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.